These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The interaction of hexafluorenium with other neuromuscular blocking agents in man. Foldes FF Anaesthesist; 1966 Mar; 15(3):75-8. PubMed ID: 4383609 [No Abstract] [Full Text] [Related]
3. The effects of succinylcholine, decamethonium, hexacarbacholine, gallamine and dimethyl tubocurarine on the twitch and tonic neuromuscular systems of the cat. Katz RL; Eakins KE J Pharmacol Exp Ther; 1966 Nov; 154(2):303-9. PubMed ID: 5922992 [No Abstract] [Full Text] [Related]
8. Pharmacology and use of muscle relaxants in infants and children. Nugent SK; Laravuso R; Rogers MC J Pediatr; 1979 Mar; 94(3):481-7. PubMed ID: 423041 [TBL] [Abstract][Full Text] [Related]
9. Lithium carbonate and neuromuscular blocking agents. Hill GE; Wong KC; Hodges MR Anesthesiology; 1977 Feb; 46(2):122-6. PubMed ID: 835845 [TBL] [Abstract][Full Text] [Related]
10. A new theory of the termination of action of the muscle relaxants. Feldman SA; Tyrrell MF Proc R Soc Med; 1970 Jul; 63(7):692-5. PubMed ID: 4317548 [No Abstract] [Full Text] [Related]
11. The interactions of neuromuscular blocking agents in man: the role of hexafluorenium. Torda TA; Foldes FF; Bailey RJ; Klonymus DH; Kuwabara S Anesthesiology; 1967; 28(6):1010-9. PubMed ID: 4383425 [No Abstract] [Full Text] [Related]
12. Interaction of the neuromuscular blocking drugs alcuronium, decamethonium, gallamine, pancuronium, ritebronium, tercuronium and d-tubocurarine with muscarinic acetylcholine receptors in the heart and ileum. Nedoma J; Dorofeeva NA; Tucek S; Shelkovnikov SA; Danilov AF Naunyn Schmiedebergs Arch Pharmacol; 1985 Apr; 329(2):176-81. PubMed ID: 4010794 [TBL] [Abstract][Full Text] [Related]